New research may lead to new approach to detect prostate cancer

Jul 24, 2012
Treating samples with a special enzyme, S&T undergraduate student Casey Burton discovered that the greater the concentration of the metabolite sarcosine, the less the samples fluoresced, or glowed, under ultraviolet light.

(Phys.org) -- An undergraduate student's technique for detecting certain metabolites in urine samples could lead to a simpler and more accurate way to test for prostate cancer.

Developed by Casey Burton of Lake Ozark, Mo., a senior chemistry major at Missouri University of Science and Technology, the technique also could prove to be less expensive than conventional prostate-specific antigen (PSA) testing for . That is because Burton's technique does not require the use of high-tech instrumentation often used to detect metabolites. Instead, his technique relies on a simple chemical reaction as well as diagnostic equipment that is available in most .

Burton also believes his approach would be more accurate than , which "cannot accurately differentiate between benign prostate conditions and active ," Burton writes in a recent research article published in the journal Analytical Methods.

"This lack of sufficient for prostate cancer highlights the need for more effective ," he writes in his paper, "A novel enzymatic technique for determination of sarcosine in urine samples." The paper was published in , Vol. 4, 141, in January 2012.

In the journal article, Burton explains how treating urine samples with a certain enzyme can determine the concentration of the metabolite sarcosine. Enzymes interact with a substrate, or molecule, to cause a chemical reaction that can be measured through various .

Until recently, the presence of sarcosine in urine was thought to be linked to prostate cancer, but that correlation has been refuted, Burton says. Even so, his method for detecting the presence of sarcosine could be used to test for the presence of other metabolites that may be linked to various diseases. The enzyme he used is one of a broad class of enzymes that operate similarly on molecules like and , among others.

Using the enzyme sarcosine oxidase on the samples produced the chemical compound formaldehyde. Through oxidation, the formaldehyde in turn produced formic acid.

From this series of , Burton was able to determine how much sarcosine was in each sample by examining the levels of fluorescence after the enzyme treatment. The more the samples fluoresced, or glowed, the lower the level of sarcosine. Conversely, a decrease in fluorescence from the samples indicated a higher level of sarcosine. Burton validated his method with nine .

Burton's method may be applied to other that may be linked to prostate cancer, he says. But the greatest value of his process may be its ease of use.

"Instead of using fancy machinery, I can use an enzyme to make the chemical fluoresce," he says. "So we can effectively analyze our , and determine whether or not they contain ."

The system's low cost when compared to traditional is also a plus, Burton says.

"This costs a tenth of a penny per sample, compared with the $70 or so it costs to get a PSA test at a health clinic or doctor's office," he says.

Burton works with Dr. Yinfa Ma, a Curators' Teaching professor of chemistry at Missouri S&T and creator of an instrument, called the P-scan, which can be used to screen urine for oncopterine and six other pteridine biomarkers. Oncopterine exists only in the urine of cancer patients.

Ma and Sanjeewa Gamagedara, who recently graduated from Missouri S&T in 2012 with a Ph. D. in chemistry, co-authored the article with Burton.

Explore further: Celebrating 100 years of crystallography

More information: Paper: pubs.rsc.org/en/Content/Articl… g/2012/AY/c1ay05541k

add to favorites email to friend print save as pdf

Related Stories

Metabolite Linked to Aggressive Prostate Cancer

Feb 11, 2009

Researchers from the University of Michigan Comprehensive Cancer Center have identified a panel of small molecules, or metabolites, that appear to indicate aggressive prostate cancer.

Urine test shows prostate cancer risk

Aug 03, 2011

A new urine test can help aid early detection of and treatment decisions about prostate cancer, a study from the University of Michigan Comprehensive Cancer Center and the Michigan Center for Translational Pathology finds.

Recommended for you

Proteins: New class of materials discovered

2 hours ago

Scientists at the Helmholtz Center Berlin along with researchers at China's Fudan University have characterized a new class of materials called protein crystalline frameworks.

The fluorescent fingerprint of plastics

22 hours ago

LMU researchers have developed a new process which will greatly simplify the process of sorting plastics in recycling plants. The method enables automated identification of polymers, facilitating rapid separation ...

User comments : 0